EDMONTON, May 13 /CNW/ - BioMS Medical Corp (TSX: MS), a leading
developer in the treatment of multiple sclerosis (MS), today announced that
Dr. Mark Krantz, Vice President Scientific Affairs, BioMS Medical, will
present at the TIDES(R) - Oligonucleotide and Peptide Technology and Product
Development Conference in Las Vegas.
